Atreca Inc (BCEL)
0.092
0.00 (0.00%)
USD |
OTCM |
May 15, 15:19
Atreca Shareholders Equity (Quarterly): 10.76M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 10.76M |
| June 30, 2023 | 44.67M |
| March 31, 2023 | 60.97M |
| December 31, 2022 | 78.41M |
| September 30, 2022 | 96.25M |
| June 30, 2022 | 115.20M |
| March 31, 2022 | 137.78M |
| December 31, 2021 | 154.93M |
| September 30, 2021 | 175.43M |
| June 30, 2021 | 198.60M |
| Date | Value |
|---|---|
| March 31, 2021 | 221.40M |
| December 31, 2020 | 242.06M |
| September 30, 2020 | 261.28M |
| June 30, 2020 | 154.12M |
| March 31, 2020 | 170.14M |
| December 31, 2019 | 186.95M |
| September 30, 2019 | 205.00M |
| June 30, 2019 | 218.88M |
| March 31, 2019 | 104.30M |
| December 31, 2018 | -93.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.76M
Minimum
Sep 2023
261.28M
Maximum
Sep 2020
151.82M
Average
162.53M
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalent Inc | 3.611B |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.34M |
| Total Liabilities (Quarterly) | 15.58M |